Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas von KAMINSKI, Mark S, ZELENETZ, Andrew D, WAHL, Richard L, KNOX, Susan J, VOSE, Julie M, PRESS, Oliver W, SALEH, Mansoor, LEONARD, John, FEHRENBACHER, Louis, LISTER, T. Andrew, STAGG, Robert J, TIDMARSH, George F, KROLL, Stew

Volltext

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma von KAMINSKI, M. S, ZASADNY, K. R, GLENN, S. D, WAHL, R. L, FRANCIS, I. R, FENNER, M. C, ROSS, C. W, MILIK, A. W, ESTES, J, TUCK, M, REGAN, D, FISHER, S

Volltext

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas von VOSE, J. M, WAHL, R. L, SALEH, M, ROHATINER, A. Z, KNOX, S. J, RADFORD, J. A, ZELENETZ, A. D, TIDMARSH, G. F, STAGG, R. J, KAMINSKI, M. S

Volltext

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016 von Shadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S, Spier, C. M, Gopal, A. K, Dakhil, S., LeBlanc, M., Smith, S. M., Friedberg, J. W

Volltext

Iodine-131 anti-B1 antibody for B-cell lymphoma : An update on the michigan Phase I experience von WAHL, R. L, ZASADNY, K. R, MACFARLANE, D, FRANCIS, I. R, ROSS, C. W, ESTES, J, FISHER, S, REGAN, D, KROLL, S, KAMINSKI, M. S

Volltext

Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody von Kaminski, Mark S, Zasadny, Kenneth R, Francis, Isaac R, Milik, Adam W, Ross, Charles W, Moon, Scott D, Crawford, Shelley M, Burgess, Jeanne M, Petry, Neil A, Butchko, Gregory M, Glenn, Stephan D, Wahl, Richard L

Volltext

Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan expe... von Kaminski, M S, Estes, J, Zasadny, K R, Francis, I R, Ross, C W, Tuck, M, Regan, D, Fisher, S, Gutierrez, J, Kroll, S, Stagg, R, Tidmarsh, G, Wahl, R L

Volltext

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas von Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A

Volltext

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma von KAMINSKI, MS, FIG, LM, ZASADNY, KR, KORAL, KF, DELROSARIO, RB, FRANCIS, IR, HANSON, CA, NORMOLLE, DP, MUDGETT, E, LIU, CP, MOON, S, SCOTT, P, MILLER, RA, WAHL, RL

Volltext

Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens von Nordøy, T., Kolstad, A., Tuck, M.K., Aaberge, I.S., Husebekk, A., Kaminski, M.S.

Volltext

Nonmyeloablative Iodine-131 Anti-B1 Radioimmunotherapy as Outpatient Therapy von Gates, Vanessa L, Carey, James E, Siegel, Jeffry A, Kaminski, Mark S, Wahl, Richard L

Volltext

Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma : Preliminary Report von KORAL, K. F, DEWARAJA, Y, CLARKE, L. A, LI, J, ZASADNY, K. R, ROMMELFANGER, S. G, FRANCIS, I. R, KAMINSKI, M. S, WAHL, R. L

Volltext

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein von Kaminski, MS, Kitamura, K, Maloney, DG, Levy, R

Volltext

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) von Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J.F., Kelly, K., Gribben, J., Pfreunschuh, M., Morschhauser, F., Schoder, H., Zelenetz, A.D., Rademaker, J., Advani, R., Valente, N., Fortpied, C., Witzig, T.E., Sehn, L.H., Engert, A., Fisher, R.I., Zinzani, P.-L., Federico, M., Hutchings, M., Bollard, C., Trneny, M., Elsayed, Y.A., Tobinai, K., Abramson, J.S., Fowler, N., Goy, A., Smith, M., Ansell, S., Kuruvilla, J., Dreyling, M., Thieblemont, C., Little, R.F., Aurer, I., Van Oers, M.H.J., Takeshita, K., Gopal, A., Rule, S., de Vos, S., Kloos, I., Kaminski, M.S., Meignan, M., Schwartz, L.H., Leonard, J.P., Schuster, S.J., Seshan, V.E.

Volltext

Acute liver failure due to hepatic involvement by hematologic malignancy von SHEHAB, T. M, KAMINSKI, M. S, LOK, A. S. F

Volltext

HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin von Bitar, Khalil N., Kaminski, Mark S., Hailat, Nabil, Cease, Kemp B., Strahler, John R.

Volltext

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants von Kaminski, MS, Kitamura, K, Maloney, DG, Campbell, MJ, Levy, R

Volltext

CT-SPECT Fusion Plus Conjugate Views for Determining Dosimetry in Iodine-131-Monoclonal Antibody Therapy of Lymphoma Patients von Koral, Kenneth F, Zasadny, Kenneth R, Kessler, Marc L, Luo, Jian-Qiao, Buchbinder, Steven F, Kaminski, Mark S, Francis, Isaac, Wahl, Richard L

Volltext

IMPROVED DELIVERY OF RADIOLABELED ANTI-B1 MONOCLONAL-ANTIBODY TO RAJI LYMPHOMA XENOGRAFTS BY PREDOSING WITH UNLABELED ANTI-B1 MONOCLONAL-ANTIBODY von BUCHSBAUM, DJ, WAHL, RL, GLENN, SD, NORMOLLE, DP, KAMINSKI, MS

Volltext

Preliminary results from intensity‐based CT‐SPECT fusion in I‐131 anti‐B1 monoclonal‐antibody therapy of lymphoma von Koral, Kenneth F., Lin, Shuhong, Fessler, Jeffrey A., Kaminski, Mark S., Wahl, Richard L.

Volltext